Media Room



Latest News Releases
Mar 20, 2017

Nektar Therapeutics (Nasdaq: NKTR) today announced positive results from the SUMMIT-07 Phase 3 efficacy study of NKTR-181, a first-in-class opioid analgesic. NKTR-181 is a new chemical entity...

Mar 2, 2017

Nektar Therapeutics (Nasdaq: NKTR) announced today that its corporate presentation will be webcast at the upcoming Cowen and Company 37th Annual Health Care Conference on Tuesday, March 7, 2017 at...

Mar 1, 2017

Nektar Therapeutics (Nasdaq: NKTR) today announced five data presentations will be delivered at the upcoming American Association for Cancer Research (AACR) Annual Meeting, which will be held...

More »

Multimedia Libraries
Media Contacts
Dan Budwick
Pure Communications, Inc.

More »

Follow Us on LinkedIn
Follow Us on Twitter

print email
Site Map Privacy Terms of Use Compliance Policy Trademarks Site Users Guide